Data-Powered Companion Diagnostics Development: A Case Study in Regulatory Innovation

• Discover insights from Merck KGaA and Foundation Medicine’s innovative collaboration leveraging real-world evidence for CDx regulatory approval
• Explore how creative approaches to overcoming sample limitations enabled approval for a NSCLC CDx for TEPMETKO® (tepotinib)
• Learn how the right CDx partnership can reduce risk and accelerate patient access to therapy

Speakers:

Varun Pattani

Senior Director & Head of Diagnostic Development

Foundation Medicine

Christoph Menzel

Head CDx Biomarker Strategy

Merck KGaA